These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8735833)

  • 1. New pentamidine related substances which simultaneously inhibit platelet aggregation and accelerate plasmin generation and in vitro clot lysis.
    Udvardy M; Posan E; Harsfalvi J; Dinya Z
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):256-8. PubMed ID: 8735833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid peptide containing RGDF (Arg-Gly-Asp-Phe) coupled with the carboxy terminal part of alpha 2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis.
    Udvardy M; Schwartzott D; Jackson K; McKee PA
    Blood Coagul Fibrinolysis; 1995 Feb; 6(1):11-6. PubMed ID: 7795148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new thrombocyte aggregation-inhibiting and fibrinolysis-promoting synthetic molecule: RGDF (Arg-Gly-Asp-Phe) coupled with the carboxyterminal antiplasmin peptide].
    Udrardy M; Schwartzott D; Jackson K; McKee PA
    Orv Hetil; 1995 Jan; 136(3):129-33. PubMed ID: 7870410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of platelet function and coagulation by pentamidine isethionate.
    Kempin SJ; Jackson CW; Edwards CC
    Antimicrob Agents Chemother; 1977 Oct; 12(4):451-4. PubMed ID: 921238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The In Vitro Effects of Pentamidine Isethionate on Coagulation and Fibrinolysis.
    Al-Horani RA; Clemons D; Mottamal M
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31174390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGDFAP: platelet aggregation inhibitory and profibrinolytic hybrid peptide (RGDF coupled with the carboxy terminal part of alpha 2-antiplasmin) enhances plasminogen binding to platelets.
    Udvardy M; Schwartzott D; Jackson K; Posan E; Rak K; McKee PA
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):481-5. PubMed ID: 8589217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
    Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW
    Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin- and plasmin-like and platelet-aggregation-inducing activities of Plumeria alba L. latex: Action of cysteine protease.
    Kusuma CG; Gubbiveeranna V; Sumachirayu CK; Bhavana S; Ravikumar H; Nagaraju S
    J Ethnopharmacol; 2021 Jun; 273():114000. PubMed ID: 33705919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peptides as inhibitors of thrombin coagulation activity and of thrombocyte aggregation].
    Pastorova VE; Liapina LA; Cherkasova KA; Ashmarin IP
    Usp Fiziol Nauk; 1999; 30(2):80-91. PubMed ID: 10420478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of thrombin- and plasmin-induced platelet aggregation by a synthetic peptide disulfide.
    Puri RN; Hu CJ; Bradford HN; Matsueda R; Umeyama H; Colman RW
    Trans Assoc Am Physicians; 1989; 102():13-9. PubMed ID: 2561638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
    Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
    Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
    Ruggiero M; Lapetina EG
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3456-9. PubMed ID: 3458190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet reactivity in thromboelastometry. Revision of the FIBTEM test: a basic study.
    Biolik G; Kokot M; Sznapka M; Święszek A; Ziaja D; Pawlicki K; Ziaja K
    Scand J Clin Lab Invest; 2017 May; 77(3):216-222. PubMed ID: 28276730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation.
    Bode C; Meinhardt G; Runge MS; Freitag M; Nordt T; Arens M; Newell JB; Kübler W; Haber E
    Circulation; 1991 Aug; 84(2):805-13. PubMed ID: 1860223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin-induced platelet aggregation is accompanied by cleavage of aggregin and indirectly mediated by calpain.
    Puri RN; Zhou FX; Colman RF; Colman RW
    Am J Physiol; 1990 Dec; 259(6 Pt 1):C862-8. PubMed ID: 2148055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of platelet agglutination and aggregation by aromatic amidino compounds.
    Geratz JD; Tidwell RR; Brinkhous KM; Mohammad SF; Dann O; Loewe H
    Thromb Haemost; 1978 Apr; 39(2):411-25. PubMed ID: 580990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregation.
    Ruef J; Nordt TK; Peter K; Runge MS; Kübler W; Bode C
    Thromb Haemost; 1999 Jul; 82(1):109-14. PubMed ID: 10456463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.